StockData
XTXXFOTCPharmaceutical PreparationsFiscal year ends December 31

Adastra Holdings Ltd.

Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 20-F on May 17, 2023
$0.01+0.00 (0.00%)

Close on Oct 19, 2026

About Adastra

Pharmaceutical Preparations, SIC 2834

Adastra Holdings Ltd. is an extraction and processing solutions company operating in the Canadian cannabis sector. It develops and utilizes extraction technologies, including supercritical carbon dioxide, cryogenic ethanol, and hydrocarbon systems, to process cannabis and hemp biomass into bulk distillates, oils, hydrocarbon extracts, shatter, and vaporizing products. Through its Chemia Analytics subsidiary, the company conducts analytical and organoleptic testing services, covering potency, microbial contamination, and formulation consulting. Its PerceiveMD clinic operations involve healthcare professionals providing medical cannabis consultations and therapies. Adastra serves licensed cannabis standard cultivators, micro-cultivators, processors, provincial distributors, and medical patients.

The business operates out of a centralized 13,035-square-foot facility situated in Langley, British Columbia, designed for domestic distribution across Canadian provinces and territories as well as prospective international exports under Good Manufacturing Practices standards. The company maintains its principal place of business in Langley, British Columbia, Canada, alongside a registered and records office in Vancouver, British Columbia.

Summary of the business section of Adastra's latest annual report, written by StockData.

Company profile

Company

Legal name
Adastra Holdings Ltd.
Founded
1987
Headquarters
Langley, A1
Address
5451 - 275 Street V4W3X8
Phone
(778) 715-5011
Employees
63, Dec 31, 2022
Industry
Pharmaceutical Preparations
Incorporated in
A1
Fiscal year ends
December 31
Auditor
DAVIDSON & COMPANY LLP, Vancouver, Canada

Stock & identifiers

Ticker
XTXXF
Exchange
OTC
IPO date
Jul 19, 2021
Shares outstanding
56M, Dec 31, 2022
Filer category
Non-accelerated filer
Stock splits
1-for-10 reverse, Oct 15, 2024
SEC CIK
1891512
EIN
12-0909627

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Adastra's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“We have 63 employees as of the date of this annual report.”

Corporate history

Events identified from SEC filings

DateEventDetails
May 1, 2024DeregistrationTermination of SEC registration (Form 15)
Apr 26, 2023Late filingNotification of late filing
May 3, 2022Late filingNotification of late filing